| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
118,790,000 |
| Market
Cap: |
42.71(M) |
| Last
Volume: |
19,275,386 |
Avg
Vol: |
8,941,637 |
| 52
Week Range: |
$0.3595 - $0.3595 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Novavax is a biotechnology company that promotes improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, NVX-CoV2373, and its primary influenza vaccine candidate, NanoFlu, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 and NanoFlu include the use of Co.'s proprietary Matrix-M™ adjuvant.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
6,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$43,042 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
47,312 |
47,312 |
47,312 |
47,312 |
| Total Sell Value |
$657,637 |
$657,637 |
$657,637 |
$657,637 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
1 |
1 |
1 |
1 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Glenn Gregory M |
President, R&D |
• – – |
2020-08-18 |
4 |
OE |
$25.60 |
$1,876,525 |
D/D |
55,921 |
57,760 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2020-06-18 |
4 |
S |
$59.53 |
$997,103 |
D/D |
(16,749) |
1,839 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2020-06-18 |
4 |
OE |
$42.20 |
$706,808 |
D/D |
16,749 |
18,588 |
|
- |
|
| Mott David M |
Director |
– • – |
2020-06-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
64,961 |
|
- |
|
| Young James F |
Director |
– • – |
2020-06-03 |
4 |
B |
$48.83 |
$73,245 |
I/I |
1,500 |
1,500 |
2.1 |
- |
|
| Herrmann John A Iii |
SVP, General Counsel |
• – – |
2020-05-18 |
4 |
S |
$49.44 |
$640,792 |
D/D |
(12,961) |
275 |
|
- |
|
| Herrmann John A Iii |
SVP, General Counsel |
• – – |
2020-05-18 |
4 |
OE |
$25.60 |
$339,448 |
D/D |
12,961 |
5,737 |
|
- |
|
| Herrmann John A Iii |
SVP, General Counsel |
• – – |
2020-03-08 |
4 |
D |
$12.48 |
$2,172 |
D/D |
(174) |
275 |
|
- |
|
| Herrmann John A Iii |
SVP, General Counsel |
• – – |
2020-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
449 |
449 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2020-03-08 |
4 |
D |
$12.48 |
$3,669 |
D/D |
(294) |
1,839 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2020-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
760 |
2,133 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2020-03-08 |
4 |
D |
$12.48 |
$24,860 |
D/D |
(1,992) |
20,494 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2020-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,072 |
22,486 |
|
- |
|
| Trizzino John |
SVP, CBO and CFO |
• – – |
2020-03-08 |
4 |
D |
$12.48 |
$2,259 |
D/D |
(181) |
5,087 |
|
- |
|
| Trizzino John |
SVP, CBO and CFO |
• – – |
2020-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
468 |
5,268 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2020-01-31 |
4 |
B |
$3.86 |
$4,825 |
D/D |
1,250 |
1,373 |
2.66 |
- |
|
| Mcmanus Michael A Jr |
Director |
– • – |
2019-11-18 |
4 |
S |
$3.82 |
$15,015 |
D/D |
(3,929) |
9,951 |
|
- |
|
| Herrmann John A Iii |
SVP, General Counsel |
• – – |
2019-09-17 |
4 |
S |
$7.07 |
$25,757 |
D/D |
(3,643) |
0 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2019-09-13 |
4 |
S |
$6.18 |
$59,476 |
D/D |
(9,620) |
123 |
|
- |
|
| Trizzino John |
SVP, CBO and CFO |
• – – |
2019-09-11 |
4 |
S |
$5.72 |
$31,911 |
D/D |
(5,578) |
4,800 |
|
- |
|
| Herrmann John A Iii |
SVP, General Counsel |
• – – |
2019-09-08 |
4 |
D |
$5.50 |
$9,037 |
D/D |
(1,643) |
3,643 |
|
- |
|
| Herrmann John A Iii |
SVP, General Counsel |
• – – |
2019-09-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,933 |
5,286 |
|
- |
|
| Trizzino John |
SVP, CBO and CFO |
• – – |
2019-09-08 |
4 |
D |
$5.50 |
$9,422 |
D/D |
(1,713) |
10,378 |
|
- |
|
| Trizzino John |
SVP, CBO and CFO |
• – – |
2019-09-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,143 |
12,091 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2019-09-08 |
4 |
D |
$5.50 |
$13,937 |
D/D |
(2,534) |
9,743 |
|
- |
|
453 Records found
|
|
Page 14 of 19 |
|
|
